☆ 4.5 Article

Early onset frontotemporal dementia following cannabis abuse: a case report

BMC PSYCHIATRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Psychiatry

Risks and Benefits of Cannabis and Cannabinoids in Psychiatry

Kevin P. Hill et al.

Summary: This review aims to outline the evidence for the therapeutic use of cannabinoids for specific medical conditions and the potential side effects associated with acute and chronic cannabis use. The results show that there are currently no approved psychiatric indications for cannabinoids, and the evidence supporting their use in the treatment of psychiatric disorders is limited. The strongest evidence for cannabinoid prescription is for the management of pain and spasticity.

AMERICAN JOURNAL OF PSYCHIATRY (2022)

添加到收藏夹

Article Behavioral Sciences

Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice

Fabian Kreilaus et al.

Summary: This study investigated the therapeutic effects of CBD on transgenic mice and found that CBD can improve behavioural deficits and cognitive impairments associated with FTD and AD.

BEHAVIOURAL BRAIN RESEARCH (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration-Insights into disease mechanisms and current therapeutic approaches

Nadine Huber et al.

Summary: Frontotemporal lobar degeneration (FTLD) is a group of fatal neurodegenerative diseases for which there are no validated diagnostic or prognostic biomarkers or effective treatments. Research suggests that targeting disturbances in neurotransmitter systems may offer new therapeutic options for treating patients with FTLD.

MOLECULAR PSYCHIATRY (2022)

添加到收藏夹

Article Psychiatry

Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife

Madeline H. Meier et al.

Summary: Long-term cannabis use is associated with cognitive deficits and smaller hippocampal volume in midlife, which may increase the risk of dementia.

AMERICAN JOURNAL OF PSYCHIATRY (2022)

添加到收藏夹

Article Clinical Neurology

Advances in Treatment of Frontotemporal Dementia

Nahuel Magrath Guimet et al.

Summary: This review explores the clinical features and treatment of frontotemporal dementia (FTD). The unique clinical features of FTD include disinhibition, apathy, loss of empathy, and compulsions. Tau and TDP-43 are the major proteins found aggregated in the brain in FTD, while a minority of patients have FET protein aggregates, primarily the FUS protein. Genetic causes of FTD include mutations in MAPT, GRN, and C9orf72 genes. Currently, there are no medications that can slow the progression of FTD, but new therapies for the genetic forms of FTD are being tested in clinical trials. Once a diagnosis is made, therapy should focus on the patient and their family, with attention to alleviating the burden of caregiving. Legal and financial advice can also be helpful. Environmental changes to manage abnormal behaviors are essential. Most compounds used to treat Alzheimer's disease dementia are not effective in FTD, and cholinesterase inhibitors and memantine should be avoided. Although limited, there is some evidence that antidepressants and second-generation antipsychotics may help individual FTD patients.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

添加到收藏夹

Review Neurosciences

Cannabinoids in Late Life Parkinson's Disease and Dementia: Biological Pathways and Clinical Challenges

Alana C. C. Costa et al.

Summary: The use of cannabinoids as therapeutic drugs has increased among aging populations. Cannabidiol (CBD) has been found to have therapeutic effects on neurodegenerative disorders such as Parkinson's disease and Alzheimer's. In clinical practice, cannabinoids are being used as adjuvant therapy for symptom relief in Parkinson's disease and Alzheimer's, although strong evidence from clinical trials is still lacking.

BRAIN SCIENCES (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Potency and Therapeutic THC and CBD Ratios: US Cannabis Markets Overshoot

Sarah D. Pennypacker et al.

Summary: Based on the analysis of online herbal dispensary products from nine U.S. states, it was found that most medical and recreational cannabis products may have THC:CBD ratios capable of causing significant acute intoxication, and this holds true across states with differing market policies. Patients seeking therapeutic benefits from cannabis products are at risk of unwanted side effects regardless of whether they obtain products from medical or recreational programs.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Clinical Neurology

Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics

Lucia Migliore et al.

Summary: Alzheimer's disease (AD) is likely to have a complex etiology involving both genetic and environmental factors. Environmental factors such as diet, lifestyle, alcohol, smoking, and pollutants may interact with genetic factors to induce epigenetic modifications of key AD-associated genes and pathways.

NATURE REVIEWS NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration

Stefanie Danielle Pina-Escudero et al.

Summary: This case study presents a patient with behavioral variant of frontotemporal dementia (bvFTD) who exhibited awake bruxism. Despite receiving multiple treatments with only partial response, the patient experienced significant relief of grinding after using a CBD capsule. Standardized pharmacological treatment for bruxism in patients with bvFTD is still lacking, suggesting a case-by-case approach and the potential adjunctive use of CBD for awake bruxism.

NEUROCASE (2021)

添加到收藏夹

Article Psychiatry

Association of Cannabis Use During Adolescence With Neurodevelopment

Matthew D. Albaugh et al.

Summary: The study highlights the association between cannabis use during adolescence and altered neurodevelopment, particularly in cortices rich in cannabinoid 1 receptors and undergoing the greatest age-related thickness change in middle to late adolescence.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Article Clinical Neurology

Cannabinoids in the management of frontotemporal dementia: a case series

Ganesh Gopalakrishna et al.

Summary: The use of cannabinoids in the management of treatment-resistant Bv-FTD patients shows potential for improving behavior and addressing primary indications for prescription.

NEURODEGENERATIVE DISEASE MANAGEMENT (2021)

添加到收藏夹

Review Behavioral Sciences

Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis

Pedro Rafael Figueiredo et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)

添加到收藏夹

Review Psychology, Clinical

What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis

Janni Leung et al.

ADDICTIVE BEHAVIORS (2020)

添加到收藏夹

Article Nutrition & Dietetics

Dietary Habits and Risk of Early-Onset Dementia in an Italian Case-Control Study

Tommaso Filippini et al.

NUTRIENTS (2020)

添加到收藏夹

Article Clinical Neurology

Case Report: Early-Onset Behavioral Variant Frontotemporal Dementia in Patient With Retrotransposed Full-Length Transcript of Matrin-3 Variant 5

Madelyn Castro et al.

FRONTIERS IN NEUROLOGY (2020)

添加到收藏夹

Article Environmental Sciences

Environmental Risk Factors for Early-Onset Alzheimer's Dementia and Frontotemporal Dementia: A Case-Control Study in Northern Italy

Giorgia Adani et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Review Clinical Neurology

Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies

Valentina Lorenzetti et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Adolescent exposure Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons

Michael L. Miller et al.

MOLECULAR PSYCHIATRY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects

Laura M. Dryburgh et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Anxiety and Depression as Risk Factors in Frontotemporal Dementia and Alzheimer's Disease: The HUNT Study

Hege Rasmussen et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Deficits in striatal dopamine release in cannabis dependence

E. van de Giessen et al.

MOLECULAR PSYCHIATRY (2017)

添加到收藏夹

Article Neurosciences

Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia

Daniel G. Amen et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

添加到收藏夹

Review Public, Environmental & Occupational Health

What is the role of modifiable environmental and lifestyle risk factors in young onset dementia?

Monica Cations et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)

添加到收藏夹

Review Clinical Neurology

The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry

Serggio C. Lanata et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

添加到收藏夹

Review Neurosciences

Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review

Samantha J. Broyd et al.

BIOLOGICAL PSYCHIATRY (2016)

添加到收藏夹

Article Clinical Neurology

Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex

Justine Renard et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Frontotemporal dementia

Jee Bang et al.

LANCET (2015)

添加到收藏夹

Article Geriatrics & Gerontology

The Patterns of Inheritance in Early-Onset Dementia: Alzheimer's Disease and Frontotemporal Dementia

Anna I. Jarmolowicz et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2015)

添加到收藏夹

Article Neurosciences

Long-Term Effects of Cannabis on Brain Structure

Giovanni Battistella et al.

NEUROPSYCHOPHARMACOLOGY (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.